nach oben

Journal of Bone and Mineral Metabolism

Erschienen in:

27.06.2022 | Original Article

Impact of adherence to CKD-MBD guidelines on mortality among Japanese dialysis patients: an ecological study

Erschienen in: Journal of Bone and Mineral Metabolism | Ausgabe 5/2022

Einloggen, um Zugang zu erhalten

Abstract

Introduction

This study evaluated the association between prefecture-level achievement of chronic kidney disease-mineral and bone disorder (CKD-MBD) parameter targets and mortality in Japanese dialysis patients.

Materials and methods

We conducted an ecological study of all prefectures in Japan using data from the Japanese Society of Dialysis Therapy and National Vital Statistics between 2016 and 2017. We calculated adherence rates to recommend target ranges for CKD-MBD parameters, including phosphate, corrected calcium, and parathyroid hormone (PTH), and explored associations of these rates with prefecture-specific standardized mortality rates (SMRs) among the general population and among prevalent dialysis patients using bivariate association analysis and structural equation modeling.

Results

Prefecture-level adherence to the target phosphate range was significantly and negatively associated with prefecture-specific SMRs in men (standardized estimate (β) = − 0.61, p < 0.001) and women (β = − 0.41, p < 0.001). However, prefecture-level adherence to the target corrected calcium range was significantly and negatively associated with prefecture-specific SMRs only in men (β = − 0.28, p = 0.01). Meanwhile, prefecture-level adherence to the target PTH range was significantly and positively associated with prefecture-specific SMRs in men (β = 0.23, p = 0.04). Prefecture-level SMRs of females in the general population had a significant impact on prefecture-level SMRs of female dialysis patients (β = 0.27, p = 0.03). The models explained 52% of variance in SMR for men and 33% for women.

Conclusion

A higher prefecture-level achievement rate of the target phosphate range recommended by the Japanese CKD-MBD guidelines was associated with a lower prefecture-specific SMR in the Japanese dialysis population.

Nur mit Berechtigung zugänglich

Block GA, Klassen PS, Lazarus JM, Ofsthun N, Lowrie EG, Chertow GM (2004) Mineral metabolism, mortality, and morbidity in maintenance hemodialysis. J Am Soc Nephrol 15:2208–2218CrossRef

Kalantar-Zadeh K, Kuwae N, Regidor DL, Kovesdy CP, Kilpatrick RD, Shinaberger CS, McAllister CJ, Budoff MJ, Salusky IB, Kopple JD (2006) Survival predictability of time-varying indicators of bone disease in maintenance hemodialysis patients. Kidney Int 70:771–780CrossRef

Tentori F, Blayney MJ, Albert JM, Gillespie BW, Kerr PG, Bommer J, Young EW, Akizawa T, Akiba T, Pisoni RL, Robinson BM, Port FK (2008) Mortality risk for dialysis patients with different levels of serum calcium, phosphorus, and PTH: the dialysis outcomes and practice patterns study (DOPPS). Am J Kidney Dis 52:519–530CrossRef

Floege J, Kim J, Ireland E, Chazot C, Drueke T, de Francisco A, Kronenberg F, Marcelli D, Passlick-Deetjen J, Schernthaner G, Fouqueray B, Wheeler DC, Investigators ARO (2011) Serum iPTH, calcium and phosphate, and the risk of mortality in a European haemodialysis population. Nephrol Dial Transplant 26:1948–1955CrossRef

Taniguchi M, Fukagawa M, Fujii N, Hamano T, Shoji T, Yokoyama K, Nakai S, Shigematsu T, Iseki K, Tsubakihara Y, Committee of renal data registry of the Japanese society for dialysis therapy (2013) Serum phosphate and calcium should be primarily and consistently controlled in prevalent hemodialysis patients. Ther Apher Dial 17:221–228CrossRef

Wakasugi M, Kazama JJ, Wada A, Hamano T, Masakane I, Narita I (2019) Functional impairment attenuates the association between high serum phosphate and mortality in dialysis patients: a nationwide cohort study. Nephrol Dial Transplant 34:1207–1216CrossRef

Ketteler M, Block GA, Evenepoel P, Fukagawa M, Herzog CA, McCann L, Moe SM, Shroff R, Tonelli MA, Toussaint ND, Vervloet MG, Leonard MB (2017) Executive summary of the 2017 KDIGO chronic kidney disease-mineral and bone disorder (CKD-MBD) guideline update: what’s changed and why it matters. Kidney Int 92:26–36CrossRef

Fukagawa M, Yokoyama K, Koiwa F, Taniguchi M, Shoji T et al (2013) Clinical practice guideline for the management of chronic kidney disease-mineral and bone disorder. Ther Apher Dial 17:247–288CrossRef

Young EW, Akiba T, Albert JM, McCarthy JT, Kerr PG, Mendelssohn DC, Jadoul M (2004) Magnitude and impact of abnormal mineral metabolism in hemodialysis patients in the dialysis outcomes and practice patterns study (DOPPS). Am J Kidney Dis 44:34–38CrossRef

10.

Fouque D, Roth H, Darné B, Jean-Bouchet L, Daugas E, Drüeke TB, Hannedouche T, Jean G, London GM, Phosphorus F, Observatory C (2018) Achievement of kidney disease: improving global outcomes mineral and bone targets between 2010 and 2014 in incident dialysis patients in France: the photo-graphe3 study. Clin Kidney J 11:73–79CrossRef

11.

Noordzij M, Korevaar JC, Boeschoten EW, Dekker FW, Bos WJ, Krediet RT, Netherlands cooperative study on the adequacy of dialysis (NECOSAD) study group (2005) The kidney disease outcomes quality initiative (K/DOQI) guideline for bone metabolism and disease in CKD: association with mortality in dialysis patients. Am J Kidney Dis 46:925–932CrossRef

12.

Palomares I, Ramos R, Martin-Malo A, Merello JI, Praga M, Luño J, de Francisco AL, ORD Group (2013) Compliance with mineral metabolism targets in haemodialysis patients: moving backwards? Blood Purif 36:131CrossRef

13.

Furumatsu Y, Nagasawa Y, Yamamoto R, Iio K, Iwatani H, Matsui I, Takabatake Y, Kawada N, Shoji T, Imai E, Isaka Y, Rakugi H (2010) Specialist care and improved long-term survival of dialysis patients. Nephrol Dial Transplant 25:1930–1935CrossRef

14.

Ogata S, Yorioka N (2011) Environmental factors influencing the survival of chronic dialysis patients. Clin Exp Nephrol 15:405–409CrossRef

15.

Ogata S, Nishi S, Wakai K, Hanafusa N, Iseki K, Tsubakihara Y, Masakane I (2015) Institutional factors influencing regional differences in the 1-year survival of dialysis patients. Hemodial In 19:S5–S10CrossRef

16.

Wakasugi M, Narita I (2021) Structural equation modeling assessment of the impact of dialysis facility staffing on mortality: an ecological study. Jpn J Nephrol 63:179–186 ((in Japanese))

17.

Yoshino M, Kuhlmann MK, Kotanko P, Greenwood RN, Pisoni RL et al (2006) International differences in dialysis mortality reflect background general population atherosclerotic cardiovascular mortality. J Am Soc Nephrol 17:3510–3519CrossRef

18.

Suzuki E, Kashima S, Kawachi I, Subramanian SV (2012) Geographic inequalities in all-cause mortality in Japan: compositional or contextual? PLoS ONE 7:e39876CrossRef

19.

Masakane I, Taniguchi M, Nakai S, Tsuchida K, Wada A, Ogata S, Hasegawa T, Hamano T, Hanafusa N, Hoshino J, Goto S, Yamamoto K, Minakuchi J, Nakamoto H, On behalf of Japanese Society for Dialysis Therapy Renal Data Registry Committee (2018) Annual dialysis data report 2016. JSDT Ren Data Regist Ren Replace Ther 4:45

20.

Nitta K, Masakane I, Hanafusa N, Taniguchi M, Hasegawa T, Nakai S, Goto S, Wada A, Hamano T, Hoshino J, Joki N, Abe M, Yamamoto K, Nakamoto H, on behalf of Japanese society for dialysis therapy renal data registry committee (2019) Annual dialysis data report 2017. JSDT Ren Data Regist Ren Replace Ther 5:53

21.

Wakasugi M, Narita I (2022) Sex differences in cause-specific mortality in Japanese dialysis patients. Intern Med. https://doi.org/10.2169/internalmedicine.8981-21CrossRefPubMed

22.

Wakasugi M, Kawamura K, Yamamoto S, Kazama JJ, Narita I (2012) High mortality rate of infectious diseases in dialysis patients: a comparison with the general population in Japan. Ther Apher Dial 16:226–231CrossRef

23.

Wakasugi M, Kazama JJ, Yamamoto S, Kawamura K, Narita I (2013) Cause-specific excess mortality among dialysis patients: comparison with the general population in Japan. Ther Apher Dial 17:298–304CrossRef

24.

Wakasugi M, Matsuo K, Kazama JJ, Narita I (2015) Higher mortality due to intracerebral hemorrhage in dialysis patients: a comparison with the general population in Japan. Ther Apher Dial 19:45–49CrossRef

25.

Wakasugi M, Kazama JJ, Narita I (2016) Mortality trends among Japanese dialysis patients, 1988–2013: a joinpoint regression analysis. Nephrol Dial Transplant 31:1501–1507CrossRef

26.

Schober P, Boer C, Schwarte LA (2018) Correlation coefficients: appropriate use and interpretation. Anesth Analg 126:1763–1768CrossRef

27.

Hooper DCJ, Mullen MR (2008) Equation modelling: guidelines for determining model fit. Electron J Bus Res Methods 6:53–60

28.

Itaya T, Shimizu S, Hara T, Matsuoka Y, Fukuhara S, Yamamoto Y (2021) Association between facility-level adherence to phosphorus management guidelines and mortality in haemodialysis patients: a prospective cohort study. BMJ Open 11:e051002CrossRef

29.

Kakuta T, Ishida M, Fukagawa M (2018) Critical governance issue of parathyroid hormone assays and its selection in the management of chronic kidney disease mineral and bone disorders. Ther Apher Dial 22:220–228CrossRef

30.

Hirakata H, Nitta K, Inaba M, Shoji T, Fujii H et al (2012) Japanese society for dialysis therapy guidelines for management of cardiovascular diseases in patients on chronic hemodialysis. Ther Apher Dial 16:435CrossRef

31.

Akiba T, Hora K, Imawari M, Sato C, Tanaka E, Izumi N, Harada T, Ando R, Kikuchi K, Tomo T, Hirakata H, Akizawa T (2012) 2011 Japanese society for dialysis therapy guidelines for the treatment of hepatitis C virus infection in dialysis patients. Ther Apher Dial 16:289–310CrossRef

32.

Kukita K, Ohira S, Amano I, Naito H, Azuma N, Ikeda K, Kanno Y, Satou T, Sakai S, Sugimoto T, Takemoto Y, Haruguchi H, Minakuchi J, Miyata A, Murotani N, Hirakata H, Tomo T, Akizawa T, Vascular access construction and repair for chronic hemodialysis guideline working group, Japanese society for dialysis therapy (2015) 2011 update Japanese society for dialysis therapy guidelines of vascular access construction and repair for chronic hemodialysis. Ther Apher Dial 19:39CrossRef

33.

Watanabe Y, Yamagata K, Nishi S, Hirakata H, Hanafusa N et al (2015) Japanese society for dialysis therapy clinical guideline for “hemodialysis initiation for maintenance hemodialysis.” Ther Apher Dial 19:107

34.

Yamamoto H, Nishi S, Tomo T, Masakane I, Saito K, Nangaku M, Hattori M, Suzuki T, Morita S, Ashida A, Ito Y, Kuragano T, Komatsu Y, Sakai K, Tsubakihara Y, Tsuruya K, Hayashi T, Hirakata H (2017) 2015 Japanese society for dialysis therapy: guidelines for renal anemia in chronic kidney disease. Ren Replace Ther 3:36CrossRef

35.

Isaka Y, Hamano T, Fujii H, Tsujimoto Y, Koiwa F, Sakaguchi Y, Tanaka R, Tomiyama N, Tatsugami F, Teramukai S (2021) Optimal phosphate control related to coronary artery calcification in dialysis patients. J Am Soc Nephrol 32:723–735CrossRef

Titel: Impact of adherence to CKD-MBD guidelines on mortality among Japanese dialysis patients: an ecological study
Publikationsdatum: 27.06.2022
Erschienen in: Journal of Bone and Mineral Metabolism / Ausgabe 5/2022
Print ISSN: 0914-8779
Elektronische ISSN: 1435-5604
DOI: https://doi.org/10.1007/s00774-022-01351-5

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

Schadet Ärger den Gefäßen?

14.05.2024 Arteriosklerose Nachrichten

In einer Studie aus New York wirkte sich Ärger kurzfristig deutlich negativ auf die Endothelfunktion gesunder Probanden aus. Möglicherweise hat dies Einfluss auf die kardiovaskuläre Gesundheit.

Intervallfasten zur Regeneration des Herzmuskels?

14.05.2024 Herzinfarkt Nachrichten

Die Nahrungsaufnahme auf wenige Stunden am Tag zu beschränken, hat möglicherweise einen günstigen Einfluss auf die Prognose nach akutem ST-Hebungsinfarkt. Darauf deutet eine Studie an der Uniklinik in Halle an der Saale hin.

Klimaschutz beginnt bei der Wahl des Inhalators

14.05.2024 Klimawandel Podcast

Auch kleine Entscheidungen im Alltag einer Praxis können einen großen Beitrag zum Klimaschutz leisten. Die neue Leitlinie zur "klimabewussten Verordnung von Inhalativa" geht mit gutem Beispiel voran, denn der Wechsel vom klimaschädlichen Dosieraerosol zum Pulverinhalator spart viele Tonnen CO₂. Leitlinienautor PD Dr. Guido Schmiemann erklärt, warum nicht nur die Umwelt, sondern auch Patientinnen und Patienten davon profitieren.

Typ-2-Diabetes und Depression folgen oft aufeinander

14.05.2024 Typ-2-Diabetes Nachrichten

Menschen mit Typ-2-Diabetes sind überdurchschnittlich gefährdet, in den nächsten Jahren auch noch eine Depression zu entwickeln – und umgekehrt. Besonders ausgeprägt ist die Wechselbeziehung laut GKV-Daten bei jüngeren Erwachsenen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Abstract

Introduction

Materials and methods

Results

Conclusion

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 5/2022

Deletion of Tfam in Prx1-Cre expressing limb mesenchyme results in spontaneous bone fractures

Relationships between QUS and HR-pQCT, DXA, and bone turnover markers

Movement control during one-leg standing is important for the bone mineral density maintenance or improvement

Correction to: Epidemiology of locomotive syndrome using updated clinical decision limits: 6-year follow-ups of the ROAD study

Transcriptional regulation of FRZB in chondrocytes by Osterix and Msx2